Coxsackie A Antibody Panel Test Cost & Procedure

Coxsackie A Antibodies, Serum - The panel now includes tests against A-2, 4, 7, 9, 10, and 16 antigens. Although there is cross-reactivity between enteroviruses with CF, antibody titers do not exceed 1:8 in most healthy individuals. Therefore, detectable titers, especially those above 1:32, should be considered diagnostic.

Coxsackie A virus: In general, group A coxsackieviruses tend to infect the skin and mucous membranes and cause herpangina. acute hemorrhagic conjunctivitis; and hand-foot-and-mouth disease.

Both group A and group B coxsackieviruses can cause nonspecific febrile illness, rash, upper respiratory tract disease, and aseptic meningitis.

Benefits of the Coxsackie A  Antibody Panel full body screening?

1. Valuable and reliable health education.

2. Assessment of possible disease.

3. Early detection of potentially life-threatening medical conditions.

4. Increases chances of early treatment and possibly cure.

5 Regularly monitor existing health conditions to avoid complications.

6. Health check results can help you live longer if you make lifestyle changes.

Preparation for test

There is no need to change your diet or stop taking any medications unless directed by your doctor. Medications such as steroids, androgens, corticosteroids, and dextrans can affect the results during the process. All should be discussed with a doctor before doing anything that may manipulate the results. Your doctor will also discuss any minimal risks of the test, such as fainting or moderate pain, as part of proper treatment.

Procedure

A blood sample is carried by putting a needle into a vein in the arm. Tidy up the vein area with an alcohol swab. A blood sample is then taken by inserting a needle into a clean area of ​​the skin, preferably a visible vein. The assistant will remove the needle and bandage the area. This is done by detecting allergen-specific IgE in the collected samples. It is taken to the laboratory for further observation and study.

Limitations

•Antibodies to the Coxsackie species can be detected in uninfected individuals following moderate passive exposure to an infected host, so a positive test result does not necessarily indicate current or recent infection.

•Therefore, all Coxsackie A serology results must be correlated with patient history and all other data available to the physician.

•Samples taken during the early stages of infection may not yield detectable antibodies. If a recent infection is suspected, he should take and test a second sample 10-20 days after the first.